《美股業績》紐交所母公司洲際交易所季績符預期 研售Euroclear部分股權
紐約證券交易所母公司洲際交易所(ICE.US)公佈第二季業績。季度純利12.52億美元,按年升1.39倍。每股季度攤薄純利2.22美元,經調整後爲1.16美元,符合市場預期。季度收入21.34億美元,按年升8.5%。其中按揭科技業務收益按年升逾5倍至3.4億美元,受惠於早前對Ellie Mae的110億美元收購。
公司4月出售加密貨幣交易所Coinbase的少數股權,套現逾12億美元。公司亦正初步探討出售歐洲最大證券清算所Euroclear的部分股權,以減低收購Ellie Mae所帶來的債務。公司於2017年以2.75億歐元收購Euroclear的有關權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.